Profile
| Metric | Value |
|---|---|
| Full Name | Becton, Dickinson and Company |
| Ticker | NYSE: BDX |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bd.com |
| Employees | 70,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $202.71 | |
| Price, 1D Change | -1.29% | |
| Market Cap | $58B | |
| TTM Dividend Yield | 2.06% | |
| PE Ratio | 34.77 | |
| Beta | 0.53 | |
| Revenue | $22B | |
| Revenue, 1Y Change | +8.24% | |
| EPS | $5.82 | |
| EPS, 1Y Change | -0.73% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.05 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 41:40 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.82 | |
| EPS Estimate | N/A | $14.94 |
| EPS Est. Change | N/A | +156.90% |
| Revenue | $21.84B | |
| Revenue Estimate | N/A | $22.52B |
| Revenue Est. Change | N/A | +3.12% |
| Current Price | $202.71 | |
| Price Target | - | $208.50 |
| Price Tgt. Change | - | +2.86% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.11 | $5.86 | -55.31% | |
| $14.38 | $5.82 | -59.55% | |
| $14.94 | N/A | +156.90% | |
| $15.88 | N/A | +173.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $20.16B | $20.18B | +0.07% | |
| $21.85B | $21.84B | -0.03% | |
| $22.52B | N/A | +3.12% | |
| $23.31B | N/A | +6.73% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -12.68% | |
| Price, 3Y | -21.84% | |
| Market Cap, 1Y | -13.20% | |
| Market Cap, 3Y | -21.42% | |
| Revenue, 1Y | +8.24% | |
| Revenue, 3Y | +15.74% | |
| EPS, 1Y | -0.73% | |
| EPS, 3Y | -1.05% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $202.71 | |
| SMA 200 | $188.03 | |
| SMA 200 vs Price | -7.24% | |
| SMA 50 | $191.49 | |
| SMA 50 vs Price | -5.54% | |
| Beta | 0.53 | |
| ATR | $3.87 | |
| 14-Day RSI | 62.77 | |
| 10-Day Volatility | 21.76% | |
| 1-Year Volatility | 30.85% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.05 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.05% | |
| Total Dividend | $4.16 | |
| Dividends Paid | $1.20B | |
| Payout Ratio | 71.28% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $21.84B | |
| EPS | $5.82 | |
| Gross Profit | $9.93B | |
| Gross Margin | 45.44% | |
| Operating Profit | $2.99B | |
| Operating Margin | 13.67% | |
| Net Income | $1.68B | |
| Net Margin | 7.68% | |
| EBITDA | $5.45B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.76 | |
| Current Ratio | 1.11 | |
| Quick Ratio | 0.64 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 2.17 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 34.77 | |
| PS Ratio | 2.65 | |
| PB Ratio | 2.28 | |
| EV/EBITDA | 14.03 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $25.39B | |
| Cash & Equivalents | $859.00M | |
| Total Assets | $55.33B | |
| Current Assets | $9.26B | |
| Total Liabilities | $29.94B | |
| Current Liabilities | $8.31B | |
| Total Debt | $19.18B | |
| Short Term Debt | $1.56B | |
| Accounts Payable | $1.97B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $20.16B | |
| Operating Expenses | $6.94B | |
| Cost Of Goods Sold | $11.92B | |
| SG&A | $5.28B | |
| D&A | $2.46B | |
| Interest Expense | $0.00 | |
| Income Tax | $203.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $3.43B | |
| CFI | -$818.00M | |
| CFF | -$3.62B | |
| Capex | $760.00M | |
| Free Cash Flow | $2.67B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B of A Securities | → | |
| RBC Capital | → | |
| Morgan Stanley | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| RBC Capital | → | |
| RBC Capital | ||
| Morgan Stanley | → | |
| Wells Fargo | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with BDX
Data Sources & References
- BDX Official Website www.bd.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/10795/000114036125035307/0001140361-25-035307-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/10795/000114036125035307/0001140361-25-035307-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- BDX Profile on Yahoo Finance finance.yahoo.com/quote/BDX
- BDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bdx
FAQ
What is the ticker symbol for Becton, Dickinson and Company?
The ticker symbol for Becton, Dickinson and Company is NYSE:BDX
Does Becton, Dickinson and Company pay dividends?
Yes, Becton, Dickinson and Company pays dividends. The last payment was $1.05, with an ex-dividend date on December 8, 2025
What sector is Becton, Dickinson and Company in?
Becton, Dickinson and Company is in the Healthcare sector
What industry is Becton, Dickinson and Company in?
Becton, Dickinson and Company is in the Medical Instruments & Supplies industry
What country is Becton, Dickinson and Company based in?
Becton, Dickinson and Company is headquartered in United States
When did Becton, Dickinson and Company go public?
Becton, Dickinson and Company initial public offering (IPO) was on February 21, 1973
Is Becton, Dickinson and Company in the S&P 500?
Yes, Becton, Dickinson and Company is included in the S&P 500 index
Is Becton, Dickinson and Company in the NASDAQ 100?
No, Becton, Dickinson and Company is not included in the NASDAQ 100 index
Is Becton, Dickinson and Company in the Dow Jones?
No, Becton, Dickinson and Company is not included in the Dow Jones index
When was Becton, Dickinson and Company last earnings report?
Becton, Dickinson and Company's most recent earnings report was on November 6, 2025
When does Becton, Dickinson and Company report earnings?
The next expected earnings date for Becton, Dickinson and Company is February 9, 2026
